Abstract:
Life-threatening illness occurs due to Aspergillus species cause a spectrum of disease ranging from airway colonization. In case
of respiratory tract, aspergilloma is the most common form of pulmonary involvement, which is usually accompanied by preexisting
lung disease finally architectural abnormalities most commonly stem from tuberculosis, although other associated conditions, such
as sarcoidosis, bronchiectasis, and neoplasm, have been documented.
Methodology: The present work comprised of synthesis and cyclization of substituted benzothiazole nucleus by reaction of
substituted aniline with potassium thiocynate in presence of bromine in glacial acetic acid and ammonia under temperature control.
Substituted benzothiazole then condensed with 2 (3 or 4)-nitrobenzoylchloride acid in presence of dry pyridine and acetone to get
substituted nitrobenzamides. To the above product 2-nitroaniline, 3-nitroaniline, 4-nitroaniline in presence of DMF were treated
to get newly synthesized derivatives (D-1 to D-09) through replacing at 7th position chlorine. Antifungal activity was performed
against Aspergillus Niger by cup plate method (diffusion technique) using Griseoflavin as standard.
Result: Among, all newly synthesized derivatives compound D-5 showed potent antifungal activity against activity. AspergillusNiger while compound D-6, D-8 and D-9 showed moderate inhibitory activity at both concentrations 50µg/ml and 100µg/ml as
compared to standard.
Conclusion: In the present work efforts have been made to synthesized newer derivatives having methyl substitution at C-6
position of benzothiazole while 2-(3 or 4)-aryl-NO2 considered as rotating substitution at C-2 and C-7 position of benzothiazole
nucleus to find out influence of activity due to change in substitution position against Aspergillus Niger.
For more Lupine
Publishers Open Access Journals please visit our
For more Theranostics
of Respiratory & Skin Diseases Journal articles please click
Here: https://www.lupinepublishers.com/respiratory-and-skin-journal/
No comments:
Post a Comment